Wednesday, August 20, 2014
FAIRFIELD-SUISUN, CALIFORNIA
99 CENTS

$1,000-a-pill Sovaldi jolts US health care system

By
From page A10 | June 18, 2014 |

WASHINGTON — Your money or your life?

Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 of 10 patients, but treatment can cost more than $90,000.

Leading medical societies recommend the drug as a first-line treatment, and patients are clamoring for it. But insurance companies and state Medicaid programs are gagging on the price. In Oregon, officials propose to limit how many low-income patients can get Sovaldi.

Yet if Sovaldi didn’t exist, insurers would still be paying in the mid-to-high five figures to treat the most common kind of hepatitis C, a new pricing survey indicates. Some of the older alternatives involve more side effects, and are less likely to provide cures.

So what’s a fair price?

The cost of this breakthrough drug is highlighting cracks in the U.S. health care system at a time of heightened budget concerns. The Obama administration has a huge political stake in controlling treatment costs, but its critics may cry rationing.

“People are going to want to try to dodge this hot potato,” says economist Douglas Holtz-Eakin.

For insurers, there’s a frustrating twist: For each middle-aged person they pay to cure with Sovaldi, any financial benefits from preventing liver failure are likely to accrue to Medicare, not to them.

More than 3 million Americans carry the hepatitis C virus, and many don’t realize it. It’s a public health concern since the disease can be transmitted by contact with infected blood, and sometimes through sexual activity. Health officials advise all baby boomers to get tested.

The illness is complex, with distinct virus types requiring different treatments. While it progresses gradually, it can ultimately destroy the liver, and transplants average $577,000.

An estimated 15,000 people died from hepatitis C in the U.S. in 2007, when it surpassed AIDS as a cause of death.

“If it’s going to get me the medicine, I’ll put my hand out there with a tin cup,” said Stuart Rose, a hepatitis C patient in New York City. His insurance would pay only $4,000 a year for medications, but Rose was able to get assistance from charitable foundations. He recently started taking Sovaldi.

Until the drug’s approval late last year, standard treatment for the most common type of the disease required daily pills and extended use of interferon, an injection that can produce debilitating flu-like symptoms. “Brain fog,” said Rose.

Taken once a day for 12 weeks, Sovaldi greatly reduces the length of interferon treatment, making things more tolerable for patients. Now, many more people might want to try the cure.

A similar drug, Olysio, also approved last year, is priced a bit lower.

The nation’s largest care provider for chronic hepatitis C, the federal Veterans Administration, sees promise. With 175,000 patients, the VA has started more than 1,850 of them on Sovaldi.

“After 20 years in infectious diseases, I never thought we would be in a position to cure this disease,” said Dr. David Ross, head of the VA’s program.

By law, the VA gets drug discounts of over 40 percent. Will the agency break even by avoiding the disease’s worst complications?

Not necessarily, said Ross. “If it leads to cost benefits in the long run, that’s gravy.”

Private insurers will probably introduce Sovaldi gradually. “Not everybody is going to get this all at once,” said former Medicare administrator Mark McClellan.

Drug maker Gilead Sciences, Inc., reported Sovaldi sales of $2.3 billion worldwide in just the first three months of this year. Gilead will not disclose its pricing methods, but vice president Gregg Alton said the drug’s high cure rate makes it “a real huge value.”

In many countries, the government sets drug prices. In the US, insurers negotiate with drug companies. Medicare is forbidden from bargaining, a situation that critics say saddles U.S. patients with high costs while subsidizing the rest of the world.

The Associated Press asked DRX, a technology company that researches drug prices for major insurers and government programs, to look at Sovaldi. The findings:

— There aren’t many deep discounts:

The midpoint — or median— discount that private payers are securing is about 14 percent off the average wholesale price of $1,200 a pill, bringing it down to $1,037. The biggest discount DRX found was nearly 36 percent, approaching the VA rate, and bringing the cost to $773. DRX surveyed more than 300 payers.

— How do other drugs compare?

DRX compared the total drug cost of treating the most common type of hepatitis C with Sovaldi and three alternatives. The regimen included pills, interferon and an antiviral called ribavirin.

Treatment with Sovaldi had the highest cost, a median of $97,376. The lowest was $48,084 for Victrelis, a somewhat older drug with a lower cure rate.

Two others were about $8,000 less than Sovaldi. The total median cost with Incivek was $89,178. With Olyisio, it was $89,319.

“While Sovaldi still is the most expensive, all of these are five-figure regimens,” said Jim Yocum, DRX executive vice president. “Sovaldi is an advance … and it doesn’t seem to be priced completely out of whack.”

But Dr. Sharon Levine, a top official working on drug policy with insurer Kaiser Permanente, disagrees.

“There was never any question that we would cover and prescribe this drug,” said Levine. But she firmly believes the price is out of line. Countries where the government sets drug prices are paying much less, she noted.

U.S. insurers aren’t interested in price controls, said Levine, but “eventually the American public is going to start getting very uncomfortable” with high prices. Drug costs have moderated in recent years, but new medications in the pipeline for cancer and other diseases are expected to push spending up.

The California Technology Assessment Forum, a private group that reviews medical treatments, recently voted Sovaldi a “low value,” because it would be cost-prohibitive to treat the high number of potentially eligible patients. But after their own assessment, the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases issued clinical guidelines recommending that doctors use Sovaldi as a primary treatment.

Meanwhile, Gilead has a new hepatitis C pill close to approval that will not require interferon use.

There’s no word on how it will be priced.

 

The Associated Press

The Associated Press

LEAVE A COMMENT

Discussion | No comments

The Daily Republic does not necessarily condone the comments here, nor does it review every post. Read our full policy

.

Solano News

Vacaville school board candidates sound off during forum

By Susan Winlow | From Page: A1 | Gallery

 
Memorial flight honors beloved Gordon Valley man

By Ian Thompson | From Page: A1, 2 Comments | Gallery

 
Recology goes pink to trash cancer

By Glen Faison | From Page: A2 | Gallery

 
Curtola park-and-ride bill goes to governor

By Barry Eberling | From Page: A3

 
City reaches milestone for train station project

By Barry Eberling | From Page: A3, 15 Comments | Gallery

 
Caltrans advises Highway 12 delays likely

By Barry Eberling | From Page: A3, 3 Comments

DUI checkpoint nets arrests in Vacaville

By Ryan McCarthy | From Page: A5, 7 Comments

 
Library’s teen board to meet next week

By Glen Faison | From Page: A5

 
South Solano Dems schedule candidates meet, greet

By Glen Faison | From Page: A5

 
Man convicted of failing to register as sex offender

By Ryan McCarthy | From Page: A5, 15 Comments | Gallery

 
Geiger sworn in as Fairfield planning commissioner

By Ryan McCarthy | From Page: A6

Faith in Action puts out call for volunteers

By Glen Faison | From Page: A6

 
 
Yippie job training program seeks applicants

By Glen Faison | From Page: A6

 
Love, a legend, come to theaters

By Amy Maginnis-Honey | From Page: A7

Suisun City police log: Aug. 17, 2014

By Glen Faison | From Page: A12

 
Fairfield police log: Aug. 16, 2014

By Glen Faison | From Page: A12

Fairfield police log: Aug. 17, 2014

By Glen Faison | From Page: A12

 
Suisun City police log: Aug. 18, 2014

By Susan Hiland | From Page: A12

Fairfield police log: Aug. 18, 2014

By Susan Hiland | From Page: A12

 
Suisun City police log: Aug. 16, 2014

By Glen Faison | From Page: A12

.

US / World

How can authorities restore order in Ferguson?

By The Associated Press | From Page: A1, 18 Comments | Gallery

 
Holder brings his civil rights push to Ferguson

By The Associated Press | From Page: A1, 3 Comments

Strong DOJ response to Ferguson seeks truth, calm

By The Associated Press | From Page: A1

 
As protests rage, Obama struggles to find his role

By The Associated Press | From Page: A1 | Gallery

Ferguson pledges outreach efforts after shooting

By The Associated Press | From Page: A1

 
Prison company pays $8 million in back wages

By The Associated Press | From Page: A6

Some evacuees of Yosemite-area fire can go home

By The Associated Press | From Page: A6 | Gallery

 
Officials say Lake Tahoe imperiled by wildfires

By The Associated Press | From Page: A8

Committee approves higher pension calculations

By The Associated Press | From Page: A8

 
Veteran rock climber killed in fall in Yosemite

By The Associated Press | From Page: A8 | Gallery

Texas Gov. Perry booked on abuse of power charges

By The Associated Press | From Page: A9, 2 Comments

 
US officials: Video shows American’s beheading

By The Associated Press | From Page: A9

NY took quick precautions after in-custody death

By The Associated Press | From Page: A10 | Gallery

 
AP Exclusive: US changing no-fly list rules

By The Associated Press | From Page: A10

Tens of thousands march on Pakistan’s parliament

By The Associated Press | From Page: A13 | Gallery

 
.

Opinion

Serve and protect? Certainly not

By Letter to the Editor | From Page: A11, 22 Comments

 
Question of the week: Does school start too soon?

By Daily Republic | From Page: A11

 
Government trying to steal rights

By Letter to the Editor | From Page: A11, 15 Comments

No getting away from corruption in state government

By Thomas Elias | From Page: A11

 
Editorial cartoons for Aug. 20, 2014

By Daily Republic Syndicated Content | From Page: A11

 
.

Living

Today in History: Aug. 20, 2014

By The Associated Press | From Page: A2

 
Community Calendar: Aug. 20, 2014

By Susan Hiland | From Page: A2

Horoscopes: Aug. 20, 2014

By Holiday Mathis | From Page: B5

 
Our daughter says she hates her mother and refuses to talk to us

By Kathy Mitchell and Marcy Sugar | From Page: B5

 
10 Things: 10 fresh ways to dress corn on the cob

By The Associated Press | From Page: B6

Think beyond the slice with refreshing watermelon

By J.M. Hirsch | From Page: B6

 
.

Entertainment

TVGrid

By Daily Republic Syndicated Content | From Page: B7

 
Dwayne ‘The Rock’ Johnson set for DC Comics film

By The Associated Press | From Page: A7

Don Pardo, iconic TV announcer, dies at 96

By The Associated Press | From Page: A7

 
Wife to bury Kasem in Norway, cites heritage

By The Associated Press | From Page: A7

.

Sports

 
Rancho Solano women’s team vying for spot in nationals

By Paul Farmer | From Page: B1 | Gallery

49ers sign defensive lineman Dorsey to extension

By The Associated Press | From Page: B1

 
49ers’ Dawson eager to get back out kicking after misses

By The Associated Press | From Page: B1 | Gallery

Kluwe, Vikings reach settlement to avert lawsuit

By The Associated Press | From Page: B2

 
Islanders announce sale of minority stake of club

By The Associated Press | From Page: B2

Ohio State: Injured QB Miller done for the season

By The Associated Press | From Page: B2

 
Past US Open champs Djokovic, Federer seeded 1-2 in U.S. Open

By The Associated Press | From Page: B2

Joe Gibbs Racing hires Carl Edwards and Daniel Suarez

By The Associated Press | From Page: B2

 
Philadelphia’s Mo’ne Davis knows hoops, too

By The Associated Press | From Page: B2

Veteran NBA ref Bavetta retires after 39 years

By The Associated Press | From Page: B2

 
Raiders still waiting for Hayden to get healthy

By The Associated Press | From Page: B2 | Gallery

As Durant steps back, US team is moving forward

By The Associated Press | From Page: B2 | Gallery

 
.

Business

Ballmer steps down from Microsoft board

By The Associated Press | From Page: B7

 
Competition heats up for Tesla’s gigafactory

By Mcclatchy-Tribune News Service | From Page: B7

Peanut, almond butter recalled for salmonella risk

By The Associated Press | From Page: B8, 1 Comment

 
McDonald’s to sell packaged coffee nationally

By The Associated Press | From Page: B8

Consumer prices edge up 0.1 percent in July

By The Associated Press | From Page: B8

 
Stocks rise as US home construction rebounds

By The Associated Press | From Page: B8

US home construction jumps 15.7 percent in July

By The Associated Press | From Page: B8, 1 Comment

 
.

Obituaries

Eddie Lee Staten

By Nancy Green | From Page: A4

 
June Canaris-Heath

By Brad Stanhope | From Page: A4

George ‘Wayne’ Hause

By Nancy Green | From Page: A4

 
Sharon Ilene Boyd

By Nancy Green | From Page: A4

Richard Ray Jr.

By Nancy Green | From Page: A4

 
Horace James Sam

By Nancy Green | From Page: A4

Joseph ‘Joey’ Kenneth Meyers

By Nancy Green | From Page: A4

 
Defrances Jean Freeman-Jefferson

By Susan Hiland | From Page: A4

.

Comics

Garfield

By Daily Republic Syndicated Content | From Page: B4

 
Wizard of Id

By Daily Republic Syndicated Content | From Page: B4

Get Fuzzy

By Daily Republic Syndicated Content | From Page: B4

 
Zits

By Daily Republic Syndicated Content | From Page: B4

Dilbert

By Daily Republic Syndicated Content | From Page: B4

 
Blondie

By Daily Republic Syndicated Content | From Page: B4

Sally Forth

By Daily Republic Syndicated Content | From Page: B4

 
Frank and Ernest

By Daily Republic Syndicated Content | From Page: B4

Peanuts

By Daily Republic Syndicated Content | From Page: B4

 
Beetle Bailey

By Daily Republic Syndicated Content | From Page: B4

For Better or Worse

By Daily Republic Syndicated Content | From Page: B4

 
Baby Blues

By Daily Republic Syndicated Content | From Page: B4

B.C.

By Daily Republic Syndicated Content | From Page: B4

 
Pickles

By Daily Republic Syndicated Content | From Page: B4

Baldo

By Daily Republic Syndicated Content | From Page: B4

 
Rose is Rose

By Daily Republic Syndicated Content | From Page: B4

Word Sleuth

By Daily Republic Syndicated Content | From Page: B5

 
Cryptoquote

By Daily Republic Syndicated Content | From Page: B5

Bridge

By Daily Republic Syndicated Content | From Page: B5

 
Crossword

By Daily Republic Syndicated Content | From Page: B5

Sudoku

By Daily Republic Syndicated Content | From Page: B5